Pfizer has appointed a chief digital officer because of the growing importance of digital technology in its R&D and business process, as part of a boardroom shake-up.
Janssen’s Stelara has shown positive results in an ulcerative colitis (UC) trial, setting up a potential new indication for the inflammatory diseases drug.
Novartis’ developmental sickle cell disease drug crizanlizumab cut occurrences of a serious complication of the disease that can lead to irreversible or fatal organ damage, according to mid